Tempest Therapeutics, Inc. (TPST) stock
TPSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$0.33−0.01 (-4.24%)
Close on Nov 17, 2026Market cap $4.85MP/E –Yield –
Tempest Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Tempest Therapeutics's price to sales ratio was 383.1× on Jan 31, 2019, against 490.4× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2019 | Jan 31, 2019 | 383.1× | +92.5 |
| 2018 | Dec 31, 2018 | 290.6× | −199.7 |
| 2017 | Sep 29, 2017 | 490.4× | +134.6 |
| 2016 | Dec 30, 2016 | 355.8× | – |
See a number that looks wrong?